Long Read Sequencing Market Growth, Key Players and Future Outlook
The long read sequencing market, valued at US$ 0.6 billion in 2023, is expected to grow to US$ 11.6 billion by 2034, driven by a CAGR of 30.96%. This growth is fueled by the rising prevalence of genetic disorders, advancements in R&D, and the increasing demand for personalized medicine.
Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5324
Long Read Sequencing Market: The Future of DNA Sequencing
Long-read sequencing (LRS) is an advanced DNA sequencing technique that determines the nucleotide sequence of long DNA strands. Unlike short-read sequencing, which requires cutting and amplifying the DNA, LRS offers a more efficient and accurate way to sequence long stretches of DNA. This method can read tens to thousands of kilobases in length, making it especially valuable for detecting large-scale mutations, such as large deletions or rearrangements in the DNA.
The growing demand for genomics research, fueled by increasing cases of genetic and chromosomal disorders, is driving the long-read sequencing market. Advances in molecular biology are also pushing the boundaries of genetic variation studies, helping to uncover mutations behind human diseases. Additionally, the rising demand for personalized medicine is further accelerating the adoption of LRS technologies.
Recent Trends in the Long Read Sequencing Market
In October 2024, Azenta Inc. launched a long-read Whole Genome Sequencing (WGS) test for clinical use, becoming the first commercial provider in the US to gain regulatory approval for this service.
That same month, PacBio announced a partnership with the National Cancer Center of Singapore (NCCS) to use its cutting-edge sequencing technologies to advance cancer research and map the genomic landscape of common cancers in Asia.
In July 2024, Oxford Nanopore Technologies expanded its collaboration with Plasmidsaurus to revolutionize the plasmid sequencing market through innovative nanopore technology.
- 10x Genomics: A leader in genomic technologies, 10x Genomics offers cutting-edge solutions for single-cell analysis and long-read sequencing. Their Chromium platform allows researchers to analyze complex genomes with high accuracy, contributing to advancements in cancer research, immunology, and genetics.
- Agilent Technologies: Agilent offers a comprehensive range of genomic sequencing tools, including platforms designed for long-read sequencing. They provide solutions for high-throughput sequencing applications, helping researchers in drug discovery, clinical research, and personalized medicine.
- Azenta Life Sciences: Azenta is known for its expertise in life sciences research, offering a variety of sequencing technologies, including long-read solutions. Their recent launch of long-read Whole Genome Sequencing (WGS) for clinical applications positions them as a key player in advancing precision medicine.
- BGI Genomics: A global leader in genomics, BGI Genomics offers long-read sequencing solutions that support a variety of applications in genetic research, agriculture, and personalized medicine. BGI’s sequencing platforms are known for their high throughput and accuracy in detecting genetic variations.
- Element Biosciences: Element Biosciences specializes in providing next-gen sequencing platforms that enable highly accurate and scalable long-read sequencing. Their technology is designed to meet the growing demands of research in genomics and human health, offering cost-effective and precise solutions.
- Illumina: One of the largest names in genomic sequencing, Illumina provides a broad range of high-performance sequencing technologies, including those supporting long-read sequencing. Their platforms are widely used across clinical diagnostics, research, and precision medicine to drive breakthroughs in genomics.
- MGI: A subsidiary of BGI Group, MGI focuses on providing innovative sequencing platforms, including long-read sequencing. Their technologies are known for high throughput, precision, and scalability, helping to accelerate research in molecular biology and personalized medicine.
- Oxford Nanopore Technologies: Oxford Nanopore is renowned for its groundbreaking nanopore sequencing technology, which is ideal for long-read sequencing applications. Their portable and real-time sequencing devices are revolutionizing genomics, enabling a wide range of applications from clinical diagnostics to environmental studies.
- Pacific Biosciences (PacBio): PacBio is a pioneer in long-read sequencing technologies, with its Sequel system being a cornerstone in the market. Their PacBio platforms enable high-accuracy sequencing, which is critical for understanding complex genomes and detecting large-scale mutations.
- Qiagen: Qiagen offers a wide array of genomic solutions, including tools for long-read sequencing. Their sequencing technologies are used in a variety of applications, such as genetic research, drug discovery, and clinical diagnostics, providing high-quality insights into genetic variations.
- Quantapore, Inc.: Quantapore is focused on developing cutting-edge sequencing technologies that are specifically tailored for long-read applications. Their innovative nanopore-based sequencing platforms provide fast, accurate, and cost-effective solutions for researchers in genetics and healthcare.
- Thermo Fisher Scientific: A major player in the life sciences industry, Thermo Fisher Scientific offers a variety of genomic sequencing technologies, including solutions for long-read sequencing. Their products are widely used in research, clinical diagnostics, and drug development, supporting advancements in precision medicine and genomics.
- Universal Sequencing Technology Corporation: This company provides a range of sequencing technologies, including long-read sequencing, designed for both research and clinical applications. Their focus is on developing highly scalable and precise genomic solutions for advancing human health and personalized medicine.
Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/long-read-sequencing-market-sizing
Access exclusive insight now @ https://www.towardshealthcare.com/price/5324
We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com
Web: https://www.towardshealthcare.com
Visit Dental Specifics: https://www.towardsdental.com
Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
